CSSVX | NRGSX | CSSVX / NRGSX | |
Total Expense Ratio | 0.85 | 0.74 | 115% |
Annual Report Gross Expense Ratio | 0.85 | 0.74 | 115% |
Fund Existence | 8 years | 13 years | - |
Gain YTD | 9.300 | -2.249 | -413% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 231M | 8.92B | 3% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 2.34 | -5.61 | -42% |
Returns for 3 years | 28.41 | 6.72 | 423% |
Returns for 5 years | 9.84 | 5.76 | 171% |
Returns for 10 years | N/A | 14.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PGDRX | 12.07 | 0.06 | +0.50% |
Principal Diversified Real Asset R3 | |||
TQMVX | 19.07 | 0.06 | +0.32% |
T. Rowe Price Integrated US LCV Eq | |||
DVRPX | 18.70 | 0.06 | +0.32% |
UBS US Dividend Ruler P2 | |||
NSVAX | 14.75 | 0.03 | +0.20% |
Columbia Sm Cp Val and Inflection Inst | |||
MLRTX | 10.69 | -0.05 | -0.47% |
NYLI Winslow Large Cap Growth Class R2 |